Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of RTX Topical Solution in Patients With Interstitial Cystitis

NCT00056251 is registered in ClinicalTrials.gov with ICOS Corporation as lead sponsor.

NCT NCT00056251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00056251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of RTX Topical Solution in Patients With Interstitial Cystitis
Lead sponsor
ICOS Corporation
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2003
Completion date
August 31, 2003
Enrollment
150
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial cystitis